Portfolio company
Arcus Biosciences
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
This biopharmaceutical company develops molecules and combination therapies for patients with various forms of cancer and immune diseases.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
ArQule
This biopharmaceutical company develops targeted small molecule drug candidates to treat cancers and rare diseases for patients with unmet medical needs.
Arcellx
This biotechnology company develops cell therapies to treat patients with cancer and autoimmune diseases.
Nuvectis Pharma
This biopharmaceutical company develops precision medicines and targeted small molecule therapeutics for patients with advanced cancers and other serious conditions.
Arvinas
This biopharmaceutical company develops protein degradation therapies to treat patients with cancer and neurodegenerative diseases.
Coherus
This biopharmaceutical company develops and commercialises immuno-oncology therapies and biosimilar medicines for patients living with cancer and other serious inflammatory diseases.
Kronos Bio
This biopharmaceutical company develops small molecule therapeutics targeting transcription factors for patients with cancer and autoimmune diseases.
Pharmacyclics
This company develops small-molecule medicines for patients with cancer and immune-mediated diseases.
Arrakis Therapeutics
This biopharmaceutical company develops oral, small-molecule medicines that target RNA to treat patients with cancer, cardiovascular conditions, neurodegeneration and rare genetic diseases.